Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

SIMPLE SUMMARY: MET amplification is one of the resistance determinants after EGFR-TKI therapy in EGFR mutant NSCLC. In this study, we evaluated the emergence of MET amplification after EGFR-TKI treatment failure. The median progression-free survival associated with the most recent EGFR-TKI treatmen...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Ahn, Beung-Chul, Lee, Ji Hyun, Kim, Min Hwan, Pyo, Kyoung-Ho, Lee, Choong-kun, Lim, Sun Min, Kim, Hye Ryun, Cho, Byoung Chul, Hong, Min Hee
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8234556/
https://ncbi.nlm.nih.gov/pubmed/34205733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123096
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares